- Previous Close
43.80 - Open
45.40 - Bid 45.60 x --
- Ask 47.00 x --
- Day's Range
45.40 - 45.40 - 52 Week Range
37.40 - 61.00 - Volume
19 - Avg. Volume
14 - Market Cap (intraday)
612.201M - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
34.14 - EPS (TTM)
1.33 - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield 0.64 (1.46%)
- Ex-Dividend Date Feb 24, 2025
- 1y Target Est
--
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.
www.iradimed.comRecent News: 46K.F
View MorePerformance Overview: 46K.F
Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 46K.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 46K.F
View MoreValuation Measures
Market Cap
590.62M
Enterprise Value
544.36M
Trailing P/E
32.87
Forward P/E
27.55
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.61
Price/Book (mrq)
7.22
Enterprise Value/Revenue
8.37
Enterprise Value/EBITDA
26.90
Financial Highlights
Profitability and Income Statement
Profit Margin
26.26%
Return on Assets (ttm)
14.41%
Return on Equity (ttm)
24.31%
Revenue (ttm)
73.24M
Net Income Avi to Common (ttm)
19.23M
Diluted EPS (ttm)
1.33
Balance Sheet and Cash Flow
Total Cash (mrq)
52.23M
Total Debt/Equity (mrq)
0.18%
Levered Free Cash Flow (ttm)
3.94M